KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average: 2018-2024

Historic Inventory Average for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to $6.4 million.

  • Aquestive Therapeutics' Inventory Average rose 14.46% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 14.46%. This contributed to the annual value of $6.4 million for FY2024, which is 2.10% up from last year.
  • According to the latest figures from FY2024, Aquestive Therapeutics' Inventory Average is $6.4 million, which was up 2.10% from $6.3 million recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Inventory Average ranged from a high of $6.4 million in FY2024 and a low of $2.7 million during FY2020.
  • Over the past 3 years, Aquestive Therapeutics' median Inventory Average value was $6.3 million (recorded in 2023), while the average stood at $5.9 million.
  • As far as peak fluctuations go, Aquestive Therapeutics' Inventory Average crashed by 35.90% in 2020, and later soared by 51.07% in 2022.
  • Over the past 5 years, Aquestive Therapeutics' Inventory Average (Yearly) stood at $2.7 million in 2020, then rose by 22.16% to $3.2 million in 2021, then soared by 51.07% to $4.9 million in 2022, then climbed by 27.82% to $6.3 million in 2023, then rose by 2.10% to $6.4 million in 2024.